Staged hepatectomy for bilobar colorectal hepatic metastases
HPB, ISSN: 1365-182X, Vol: 14, Issue: 11, Page: 782-789
2012
- 14Citations
- 18Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes14
- 14
- CrossRef10
- Captures18
- Readers18
- 18
Article Description
This study describes the management of patients with bilobar colorectal liver metastases (CRLM). A retrospective collection of data on all patients with CRLM who were considered for staged resection ( n = 85) from January 2003 to January 2011 was performed. Patients who underwent one hepatic resection were considered to have had a failed staged resection (FSR), whereas those who underwent a second or third hepatic resection to produce a cure were considered to have had a successful staged resection (SSR). Survival was calculated from the date of diagnosis of liver metastases. Complete follow-up and dates of death were obtained from the Government of Quebec population database. Median survival was 46 months (range: 30–62 months) in the SSR group and 22 months (range: 19–29 months) in the FSR group. Rates of 5-year survival were 42% and 4% in the SSR and FSR groups, respectively. Fifteen of the 19 patients who remained alive at the last follow-up date belonged to the SSR group. In patients in whom staged resection for bilobar CRLM is feasible, surgery would appear to offer benefit.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1365182X15305402; http://dx.doi.org/10.1111/j.1477-2574.2012.00543.x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84867514396&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23043668; https://linkinghub.elsevier.com/retrieve/pii/S1365182X15305402; http://www.hpbonline.org/article/S1365-182X(15)30540-2/abstract
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know